Drug Shortage Report for APO-RANITIDINE TABLET 300MG

Last updated on 2019-09-18 History
Report ID 94177
Drug Identification Number 00733067
Brand name APO-RANITIDINE TABLET 300MG
Common or Proper name APO-RANITIDINE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-17
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-09-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-09-18 French Compare
v1 2019-09-18 English Compare

Showing 1 to 2 of 2